Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
Authors
Keywords
Breast cancer, Prognosis, Cancer cell migration, Kinase inhibitors, MTT assay, Cell proliferation, RNA interference, Hyperexpression techniques
Journal
PLoS One
Volume 8, Issue 2, Pages e56919
Publisher
Public Library of Science (PLoS)
Online
2013-02-21
DOI
10.1371/journal.pone.0056919
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aberrant upregulation of 14-3-3ơ expression serves as an inferior prognostic biomarker for gastric cancer
- (2011) Wei-hua Zhou et al. BMC CANCER
- Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53
- (2011) E K A Millar et al. BRITISH JOURNAL OF CANCER
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors
- (2010) Anne M. Traynor et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel
- (2009) Ewan K.A. Millar et al. JOURNAL OF CLINICAL ONCOLOGY
- Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
- (2009) X. Shang et al. MOLECULAR CANCER THERAPEUTICS
- Clinical significance of basal-like subtype in triple-negative breast cancer
- (2009) Yutaka Yamamoto et al. Breast Cancer
- Inhibition of Aurora-A suppresses epithelial–mesenchymal transition and invasion by downregulating MAPK in nasopharyngeal carcinoma cells
- (2008) Xiang-Bo Wan et al. CARCINOGENESIS
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- Triple-Negative Breast Cancer: Risk Factors to Potential Targets
- (2008) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2
- (2008) Aleix Prat et al. Nature clinical practice. Oncology
- Aurora kinase small molecule inhibitor destroys mitotic spindle, suppresses cell growth, and induces apoptosis in oral squamous cancer cells
- (2007) Caobing Pan et al. ORAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started